<DOC>
	<DOCNO>NCT00024076</DOCNO>
	<brief_summary>RATIONALE : Radiofrequency ablation use high-frequency electric current kill tumor cell . CT-guided radiofrequency ablation may effective treatment lung cancer . PURPOSE : Phase II trial study effectiveness radiofrequency ablation treat patient refractory advanced lung cancer .</brief_summary>
	<brief_title>Radiofrequency Ablation Treating Patients With Refractory Advanced Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine safety toxicity radiofrequency ablation patient refractory advance pulmonary malignancy . - Determine efficacy treatment , term local control , patient . - Determine whether CT scan reasonable image assessment tool treatment delivery follow-up patient . OUTLINE : Patients undergo percutaneous CT-guided radiofrequency ablation directly tumor 2 hour . Patients follow 1 , 3 , 6 , 12 month . PROJECTED ACCRUAL : A total 30 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Mesothelioma</mesh_term>
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Thymoma</mesh_term>
	<mesh_term>Thymus Neoplasms</mesh_term>
	<criteria>Diagnosis primary secondary intrathoracic malignancy Any cell type origin Involving intrapulmonary , mediastinal , pleural/chest wall Inoperable primary metastatic cancer lung Refractory amenable conventional therapy ( e.g. , surgery , chemotherapy , radiotherapy ) Single multiple lesion noncontiguous vital structure organ : Trachea Heart Aorta Great vessel Esophagus Less 5 cm large dimension Accessible via percutaneous transthoracic route Hepatic : Coagulation profile normal</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>recurrent non-small cell lung cancer</keyword>
	<keyword>recurrent small cell lung cancer</keyword>
	<keyword>recurrent malignant mesothelioma</keyword>
	<keyword>recurrent thymoma thymic carcinoma</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
	<keyword>pulmonary carcinoid tumor</keyword>
	<keyword>lung metastasis</keyword>
</DOC>